Dedifferentiated Liposarcoma
📧 Sign up to get email alerts when something new happens for Dedifferentiated Liposarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors [Phase 1]
Phase 1 first-in-human study of oral TP-1287 in patients with advanced solid tumors, including specific sarcoma subtypes, has been terminate…
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Selinexor in Advanced Liposarcoma [Phase 2, Phase 3]
Phase 2/3 trial of selinexor in dedifferentiated liposarcoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Ph II Cabazitaxel DD Liposarcoma [Phase 2]
Phase II trial update for cabazitaxel in dedifferentiated liposarcoma (completed).
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating nivolumab with or without ipilimumab in metastatic or unresectable sarcoma shows results from a completed study.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial [Phase 2]
Exploratory Phase II multicenter trial assessing efficacy and safety of plitidepsin in advanced unresectable/metastatic dedifferentiated lip…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of ribociclib in patients with advanced liposarcoma, including well-differentiated…
-
CLINICAL_TRIALS withdrawal · 2015-04-14Clinical Trial Update: Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma [Phase 2]
A Phase 2 trial evaluating IPI-504 for advanced dedifferentiated liposarcoma was withdrawn.